Menta Capital’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-15,451
Closed -$86K 862
2017
Q3
$86K Buy
+15,451
New +$104K 0.01% 728
2017
Q2
Sell
-44,517
Closed -$401K 962
2017
Q1
$401K Buy
+44,517
New +$464K 0.04% 623
2016
Q3
Sell
-57,527
Closed -$548K 1003
2016
Q2
$548K Buy
+57,527
New +$626K 0.08% 479

Other funds holding NPTN

Menta Capital's NPTN Position: Q4 2017 in Review

Menta Capital sold out of NEOPHOTONICS CORP (NPTN) in Q4 2017, closing a stake of 15,451 shares — an estimated $86K sold.

Menta Capital first reported a position in NPTN in Q2 2016 and held it in 3 quarters. The position peaked at $548K in Q2 2016. 92 funds tracked by Wall St. Rank hold NPTN as of Q4 2017.

  • Menta Capital reported no remaining NEOPHOTONICS CORP position as of Q4 2017 after selling out during the quarter.
  • Menta Capital sold 15,451 NEOPHOTONICS CORP shares in Q4 2017, an estimated $86K.
  • Menta Capital first reported a position in NEOPHOTONICS CORP in Q2 2016 and held it in 3 quarters.
  • Menta Capital's NEOPHOTONICS CORP position peaked at $548K in Q2 2016.
  • 92 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q4 2017.

Based on Menta Capital's 13F filing for Q4 2017, filed 14 Feb 2018.